NCT06347445View on ClinicalTrials.gov

Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients With Diabetes Mellitus-2 (TEMD-2 Study)

CompletedOBSERVATIONAL

Enrollment

5,707

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

January 30, 2023

Study Completion Date

January 30, 2023

Conditions

Diabetes Mellitus

Interventions

OTHER

There is no intervention.

There is no intervention.

Trial Locations (1)

06010

Gulhane School of Medicine Department of Endocrinology and Metabolism, Ankara

All Listed Sponsors

lead

Gulhane School of Medicine

OTHER